Back to search
Primary Intracerebral Hemorrhage
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Intracerebral Hemorrhage trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Intracerebral Hemorrhage trials you may qualify forThe goal of this clinical trial is to see if silent brain infarcts (SBIs), or stroke-like symptoms detectable during brain imaging, are a possible contributor t…
The STOP ICH trial is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) study designed to assess the efficacy and safety of atorvast…
This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3…
The investigators design an observational multi-center cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，…
The investigators design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，c…
Primary intracerebral hemorrhage (ICH) is a severe and life-threatening condition with a high mortality rate, reaching up to 50% within the first month. Survivo…
This study is designed to determine the safety and feasibility of using Cerebrolysin in treating primary intracerebral hemorrhage (ICH). This is a multicenter,…